Chemoinformatics in Drug Discovery

Oprea, Tudor I. (Herausgeber)

Methods and Principles in Medicinal Chemistry (Band Nr. 23)

1. Auflage Januar 2005
XXII, 493 Seiten, Hardcover
149 Abbildungen (21 Farbabbildungen)
39 Tabellen
Handbuch/Nachschlagewerk

ISBN: 978-3-527-30753-1

Wiley-VCH, Weinheim

Wiley Online Library Probekapitel

Kurzbeschreibung

Wie lässt sich die Wirkstoffentwicklung durch den zweckgerichteten Einsatz der Chemoinformatik beschleunigen und effektivieren? Ausgewiesene Fachleute - sowohl aus großen pharmazeutischen Unternehmen als auch aus hochspezialisierten Startup-Firmen - demonstrieren Ihnen, welche verfügbaren Programme sich für welche Probleme eignen und wie man in der Praxis Schwierigkeiten begegnet. Sie wenden sich dabei nicht an Softwareentwickler, sondern an Anwender aus allen Bereichen der pharmazeutischen Forschung und medizinischen Chemie.

Jetzt kaufen

Preis: 279,00 €

Preis inkl. MwSt, zzgl. Versand

Euro-Preise für Wiley-VCH- und Ernst & Sohn-Titel sind nur für Deutschland gültig. In EU-Ländern gilt die lokale Mehrwertsteuer. Portokosten werden berechnet.

- Gedruckte Ausgabe vergriffen -

Weitere Versionen

This handbook provides the first-ever inside view of today's integrated approach to rational drug design. Chemoinformatics experts from large pharmaceutical companies, as well as from chemoinformatics service providers and from academia demonstrate what can be achieved today by harnessing the power of computational methods for the drug discovery process.
With the user rather than the developer of chemoinformatics software in mind, this book describes the successful application of computational tools to real-life problems and presents solution strategies to commonly encountered problems. It shows how almost every step of the drug discovery pipeline can be optimized and accelerated by using chemoinformatics tools -- from the management of compound databases to targeted combinatorial synthesis, virtual screening and efficient hit-to-lead transition.
An invaluable resource for drug developers and medicinal chemists in academia and industry.

Introduction

VIRTUAL SCREENING
Chemoinformatics in Lead Discovery
Computational Chemistry, Molecular Complexity and Screening Set Design
Algorithmic Engines in Virtual Screening
Strengths and Limitations of Pharmacophore-Based Virtual Screening

HIT AND LEAD DISCOVERY
Enhancing Hit Quality and Diversity Within Assay Throughput Constraints
Molecular Diversity in Lead Discovery: From Quantity to Quality
In Silico Lead Optimization

DATABASES AND LIBRARIES
WOMBAT: World of Molecular Bioactivity
Cabinet - Chemical And Biological Informatics Network
Structure Modification in Chemical Databases
Rational Design of GPCR-specific Combinational Libraries Based on the Concept of Privileged Substructures

CHEMINFORMATICS APPLICATIONS
A Practical Strategy for Directed Compound Acquisition
Efficient Strategies for Lead Optimization
Chemoinformatic Tools for Library Design and the Hit-to-Lead Process: A User's Perspective
Application of Predictive QSAR Models to Database Mining
Drug Discovery in Academia - a Case Study

"Dieser Band ist eine hochwertige Quelle für Anwender aus der pharmazeutischen Forschung und der medizinischen Chemie."
Nachrichten aus der Chemie

"Chemoinformatics in Drug Discovery ist eine hochwertige Quelle für Anwender aus allen Bereichen der pharmazeutischen Forschung und medizinischen Chemie in Forschung und Industrie."
Angewandte Chemie

Tudor I. Oprea is Professor of Biochemistry and Molecular Biology and Chief, Division of Biocomputing at the University of New Mexico School of Medicine, Albuquerque (USA). He was born in Timisoara (Romania) where he did all his studies including his Ph.D. thesis under the supervision of Francisc Schneider. He was a post-doctoral fellow at Washington University with Garland Marshall, and Los Alamos National Laboratory with Angel Garcia. He worked six years at AstraZeneca in Mölndal (Sweden), before moving to New Mexico as full Professor in 2002. He received the Hansch Award from the QSAR and Modeling Society in 2002. He is interested in chemoinformatics, virtual screening, QSAR, and lead and drug discovery.

T. I. Oprea, University of New Mexico, Albuquerque, USA